Media Coverage
California HCAI
22 September 2026
On 22 September 2026 HCAI opened an RFI for a third-party administrator of $66 million in Budget Act programs, including $10 million for medical and pharmacy services for children and youth after the federal Medicaid and CHIP cut.
Archives of Disease in Childhood (BMJ)
18 September 2026
On 18 September 2026, Archives of Disease in Childhood published Dr. Richard Santen on intellectual conflicts of interest in clinical guidelines. The paper’s title uses “gender-affirming care”; that means puberty blockers and opposite-sex hormones for children and adolescents with gender dysphoria. Santen says a weak evidence base has been filled by conflicted expert opinion.
Acta Paediatrica — Ruuska et al.
4 April 2026
Ruuska, Tuisku, Holttinen, and Kaltiala compared 2,083 under-23s referred to Finnish gender services (1996–2019) with 16,643 matched controls. Specialist psychiatric care was already higher before referral and still higher two or more years later. It rose among those who received medical gender reassignment. The authors: psychiatric needs do not subside after that pathway.
U.S. Department of Justice
18 September 2026
Justice Department resolutions with NYU Langone Hospitals and UPMC stop puberty blockers, cross-sex hormones, and surgeries for minors, with $8.5 million and $950,000 payments.
Office of Governor Gavin Newsom
18 September 2026
On 18 September 2026 Governor Gavin Newsom signed AB 113. Item 4140-101-0001, Provision 12 sets aside $9,000,000 of state money “to support gender-affirming care services for children and youth” — sex-rejecting procedures on children — after the federal Medicaid and CHIP cut.
U.S. Department of Education
17 September 2026
On 17 September 2026 the U.S. Department of Education’s Student Privacy Policy Office opened an investigation of the Public Schools of Northborough and Southborough — including Algonquin Regional High School — for possible FERPA and PPRA violations after alleged social transition of a minor without parental knowledge or consent. That is an investigation, not a finding. The district denies. Healey attributes the DCF removal to criminal charges against the parents; the parents dispute that.
U.S. Department of Justice — amicus brief
17 September 2026
On 17 September 2026 the official Justice Department account posted the United States’ merits-stage amicus brief in International Partners for Ethical Care, Inc. v. Bob Ferguson (No. 25-840). DOJ tells the Supreme Court that parents have standing when Washington refers runaway minors seeking so-called “gender-affirming treatment” for behavioral-health services without parental consent.
Do No Harm — Greene & Kingsbury
17 September 2026
Jay Greene and Ian Kingsbury (Do No Harm) analyzed CDC completed-suicide data against state bans on puberty blockers, cross-sex hormones, and surgeries for minors. Across three models, they found no statistically significant rise in teen suicide rates after those bans took effect.
U.S. Department of Justice Press Release 26-1022, Sept. 4, 2026
4 September 2026
On September 4, 2026, the U.S. Department of Justice announced an agreement with Mount Sinai Health System resolving an investigation into potential federal-law violations arising from sex-rejecting procedures on children.
Complaint filed Sept. 2, 2026, U.S. District Court for the District of Massachusetts, No. 26-cv-14051
3 September 2026
On September 2, 2026, twenty-two states and the District of Columbia filed suit against the Department of Health and Human Services and the Centers for Medicare & Medicaid Services in the U.S. District Court for the District of Massachusetts, Civil Action No. 26-cv-14051. The complaint challenges CMS-2451-F, the August 2026 final rule ending Medicaid and CHIP payment for gender-transition procedures on minors.
AB 113 (Budget Act of 2026), enrolled Sept. 1, 2026 — Item 4140-101-0001, Provision 12
1 September 2026
On September 1, 2026, the California Legislature enrolled AB 113, an urgency end-of-session Budget Bill Junior amending the Budget Act of 2026.
HHS
13 August 2026
HHS released Wolves in White Coats, a commissioned report on insurance coding, financial incentives, and sex-rejecting procedures for minors. Claims analysis covers 2015 through 2025.
HHS
11 August 2026
CMS issued a final rule ending the use of federal Medicaid and CHIP funds to pay for sex-rejecting procedures on children and youth. The rule is scheduled to take effect October 13, 2026.
Health Research Authority
31 July 2026
On 31 July 2026, the Health Research Authority published its response to the High Court’s decision on the PATHWAYS legal challenge. Mr Justice Chamberlain refused permission to apply for a judicial review and refused the application to stop the trial.
King’s College London
26 July 2026
King’s College London, the trial’s lead sponsor, says there is not enough information about the benefits or risks of puberty-suppressing hormones for young people with gender incongruence. PATHWAYS is a research study — not routine NHS care, and not a green light.
Infoleg / Argentina.gob.ar
16 July 2026
On 16 July 2026, Argentina’s official legislative database (Infoleg) recorded that Chamber V of the Federal Contentious-Administrative Court ordered a precautionary suspension (suspensión cautelar) of Decreto DNU 62/2025 until the action is decided. This is a setback for treating the decree as an under-18 ban in force.
GOV.UK (Medicines and Healthcare products Regulatory Agency)
19 June 2026
On 19 June 2026, the Medicines and Healthcare products Regulatory Agency said it had concluded scientific dialogue with the PATHWAYS sponsor and that a modified protocol met required regulatory standards. The Health Research Authority, in parallel, approved the trial against its ethical standards.
CDC / NCHS — ICD-10-CM files
16 June 2026
From 1 October 2026, U.S. clinics can record gender dysphoria in remission and a personal history of detransition. That is tracking. Official CDC/NCHS FY2027 addenda.
U.S. Department of Justice
5 June 2026
On 5 June 2026, the U.S. Department of Justice announced a resolution with the Cleveland Clinic Foundation, together with the Ohio Attorney General. DOJ describes a decades-long commitment not to perform or offer sex-rejecting procedures on minors, including puberty blockers and cross-sex hormones.
Supreme Court of Colorado
18 May 2026
On 18 May 2026 the Supreme Court of Colorado decided In re Bella Boe et al. v. Children’s Hospital Colorado, 2026 CO 32, Case No. 26SA66. This is a setback for the hospital’s pause of pediatric medical transition.
U.S. Department of Justice
15 May 2026
On 15 May 2026, the U.S. Department of Justice announced a resolution with Texas Children’s Hospital (TCH) together with the Texas Attorney General. DOJ describes it as the first resolution under its national investigation into sex-rejecting procedures on minors.
GOV.UK (Department of Health and Social Care)
20 February 2026
On 20 February 2026, the Department of Health and Social Care said preliminary work to establish the PATHWAYS clinical trial had been paused after new concerns from the Medicines and Healthcare products Regulatory Agency (MHRA).
American Society of Plastic Surgeons
3 February 2026
ASPS advises surgeons to delay breast/chest, genital, and facial gender surgery until patients are at least 19. Cites insufficient evidence of a favorable risk–benefit ratio, low-certainty mental-health evidence, concerns about long-term harms, and irreversibility in a developmentally vulnerable population. Professional guidance.
Government of Alberta
7 January 2026
Alberta’s hormone-therapy rules for minors under Ministerial Order 31/2025 took effect on 7 January 2026. This is Alberta only, not a Canada-wide ban.
Queensland Government ministerial statement
19 December 2025
On 19 December 2025, Queensland’s Minister for Health and Ambulance Services published the Independent Review Advice Report (Professor Ruth Vine) on Stage 1 and Stage 2 hormones for children and adolescents with gender dysphoria in Queensland public hospitals, and announced Cabinet’s decision.
New Zealand Legislation
19 December 2025
On 19 December 2025 the Medicines (Restriction on Prescribing Gonadotropin-releasing Hormone Analogues) Amendment Regulations 2025 (LI 2025/256) came into force. Enforcement was later paused by the courts.
Federal Register / U.S. Government Publishing Office
19 December 2025
On 19 December 2025 the Federal Register published CMS-2451-P, a proposed rule. The later August 2026 paper is the final rule (CMS-2451-F).
NHS England
18 December 2025
On 18 December 2025 Dr David Levy’s review of England’s nine NHS adult gender dysphoria clinics found no systematic patient-outcomes data, waits of years, and more than 40,000 people waiting for a first assessment. NHS England accepted the findings. This is an operational review.
Courts of New Zealand
17 December 2025
On 17 December 2025 the High Court of New Zealand delivered Professional Association for Transgender Health Aotearoa Inc v Minister of Health [2025] NZHC 4045. This is a setback for treating the GnRH analogue regulations as a ban in force.
Government of Alberta
11 December 2025
On 11 December 2025, Alberta’s Protecting Alberta’s Children Statutes Amendment Act (Bill 9) received Royal Assent and took effect that day. This is Alberta only, not a Canada-wide ban.
U.S. Department of Health and Human Services
19 November 2025
The U.S. Department of Health and Human Services published Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices on 19 November 2025. This is an evidence review.
NHS England
30 October 2025
On 30 October 2025 NHS England asked healthcare professionals for evidence to help design a clinical pathway for adults who have already medically transitioned and now want to detransition. This is a call for evidence.
Queensland Health
28 October 2025
On 28 October 2025, Queensland’s Minister for Health and Ambulance Services issued Ministerial Direction QH-MD-002 under section 44(1) of the Hospital and Health Boards Act 2011.
Supremo Tribunal Federal
2 October 2025
On 2 October 2025, Justice Flávio Dino of Brazil’s Supremo Tribunal Federal issued a provisional decision in Reclamação (Rcl) 84653 suspending a Federal Court of Acre injunction that had paused CFM Resolution 2.427/2025.
Rebel News
12 August 2025
After years of child protection activism and more than 30 assaults, Chris Elston takes his fight against child gender ideology to the next level with the launch of the We Speak Truth Foundation.
The Daily Wire
6 August 2025
We’re formalizing a grassroots movement to educate, activate, and equip people to protect children.
Fox News
5 July 2025
Billboard Chris forces Australia to back down after a tribunal threatened X with an $800,000 fine for his post critical of a transgender WHO official.
Catholic Herald
26 June 2025
A new report from the United Nations’ Special Rapporteur on violence against women and girls warns that countries are failing to address both persistent and newly emerging forms of sex-based violence, including those that relate to gender ideology.
Politico
18 June 2025
The ruling was 6-3 along ideological lines. The Supreme Court has upheld a Tennessee law that bans sex-rejecting procedures for minors.
Conselho Federal de Medicina (CFM)
16 April 2025
Conselho Federal de Medicina (CFM) Resolution 2.427/2025 is a professional ethics / medical-board rule. It was signed 8 April 2025 and published in the Diário Oficial da União on 16 April 2025.